T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$1.76B |
| 2 |
Eli Lilly
LLY
|
+$1.4B |
| 3 |
Bank of America
BAC
|
+$1.3B |
| 4 |
Tesla
TSLA
|
+$1.19B |
| 5 |
Wells Fargo
WFC
|
+$784M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$6.47B |
| 2 |
Amazon
AMZN
|
+$3.71B |
| 3 |
Yum! Brands
YUM
|
+$2.84B |
| 4 |
Salesforce
CRM
|
+$2.77B |
| 5 |
Fortive
FTV
|
+$2.41B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.06% |
| 2 | Healthcare | 18.72% |
| 3 | Consumer Discretionary | 14.62% |
| 4 | Financials | 10.36% |
| 5 | Communication Services | 9.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
Toro Company
TTC
$9.27B
| $338M | 0.06% |
3,912,929
-488,270
| -11% | -$41.8M |
|
277
Automatic Data Processing
ADP
$107B
| $336M | 0.06% |
1,485,330
-54,930
| -4% | -$13M |
|
278
Elanco Animal Health
ELAN
$11.3B
| $335M | 0.06% |
27,030,888
+4,872,640
| +22% | +$85.2M |
|
279
Trip.com Group
TCOM
$28.3B
| $335M | 0.05% |
12,271,751
-7,616,571
| -38% | -$199M |
|
280
Starbucks
SBUX
$125B
| $335M | 0.05% |
3,976,958
-9,621,067
| -71% | -$817M |
|
281
GSK
GSK
$101B
| $331M | 0.05% |
11,184,518
-690,456
| -6% | -$26.2M |
|
282
Rexford Industrial Realty
REXR
$8.12B
| $329M | 0.05% |
6,324,817
-277,132
| -4% | -$17.2M |
|
283
FMC
FMC
$1.25B
| $326M | 0.05% |
3,085,382
+386,465
| +14% | +$41.7M |
|
284
Rockwell Automation
ROK
$49.7B
| $322M | 0.05% |
1,498,756
+764,385
| +104% | +$178M |
|
285
Tyson Foods
TSN
$19.9B
| $321M | 0.05% |
4,874,819
-580,222
| -11% | -$45.9M |
|
286
DexCom
DXCM
$34.2B
| $321M | 0.05% |
3,989,664
-103,874
| -3% | -$8.8M |
|
287
Paycom
PAYC
$9.49B
| $320M | 0.05% |
970,830
-214,360
| -18% | -$73.8M |
|
288
Bright Horizons
BFAM
$3.79B
| $317M | 0.05% |
5,504,151
-4,139,349
| -43% | -$315M |
|
289
Packaging Corp of America
PKG
$22.9B
| $317M | 0.05% |
2,821,226
-892,321
| -24% | -$121M |
|
290
Corpay
CPAY
$27.3B
| $314M | 0.05% |
1,782,897
-3,746,026
| -68% | -$803M |
|
291
Cameco
CCJ
$42.7B
| $314M | 0.05% |
11,826,801
-2,719,267
| -19% | -$69.6M |
|
292
Devon Energy
DVN
$48.4B
| $313M | 0.05% |
5,206,828
-3,399,943
| -40% | -$211M |
|
293
Regency Centers
REG
$14B
| $313M | 0.05% |
5,811,406
+282,582
| +5% | +$17.3M |
|
294
Charles River Laboratories
CRL
$13.6B
| $312M | 0.05% |
1,586,499
+482,207
| +44% | +$104M |
|
|
ETRN
295
DELISTED
Equitrans Midstream Corporation Common Stock
ETRN
| $310M | 0.05% |
41,502,504
+6,006,051
| +17% | +$50.2M |
|
296
Allstate
ALL
$65.2B
| $308M | 0.05% |
2,476,190
+2,095,124
| +550% | +$260M |
|
297
Aon
AON
$74.4B
| $308M | 0.05% |
1,148,258
-18,835
| -2% | -$5.32M |
|
298
Norfolk Southern
NSC
$76B
| $306M | 0.05% |
1,459,155
-693,020
| -32% | -$167M |
|
299
AutoZone
AZO
$49.7B
| $304M | 0.05% |
141,802
+28,025
| +25% | +$61.1M |
|
300
Mercado Libre
MELI
$92.5B
| $301M | 0.05% |
363,104
-11,193
| -3% | -$9.62M |
|
Similar funds
T. Rowe Price Associates's Q3 2022 Portfolio in Review
As of Q3 2022, T. Rowe Price Associates held 3,114 positions worth $610B, down 23% from $791B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
T. Rowe Price Associates withdrew a net $168B in Q3 2022, closing 171 positions and reducing 1,248 holdings. Its most notable exit was Alcon, an estimated $1.51B position sold in full.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, T. Rowe Price Associates opened a new position in Corebridge Financial worth $194M.
- T. Rowe Price Associates's largest Q3 2022 buy was Corebridge Financial: 9,831,688 shares worth $194M.
- T. Rowe Price Associates added most to ExxonMobil in Q3 2022, an estimated $1.76B increase.
- T. Rowe Price Associates's biggest Q3 2022 reduction was Microsoft, cutting an estimated $6.47B.
- T. Rowe Price Associates fully exited Alcon in Q3 2022, selling an estimated $1.51B.
- T. Rowe Price Associates's ten largest holdings make up 31% of its $610B portfolio in Q3 2022.
- T. Rowe Price Associates opened 154 new positions and closed 171 in Q3 2022.
- T. Rowe Price Associates's portfolio value fell 23% quarter-over-quarter to $610B.
Based on T. Rowe Price Associates's 13F filing for Q3 2022, filed 14 Nov 2022.